Galderma Group AG (GALDY)
Galderma Group Market Cap: 46.79B for Jan. 13, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| BeOne Medicines Ltd. | 38.86B |
| AC Immune SA | 371.72M |
| CRISPR Therapeutics AG | 5.361B |
| Addex Therapeutics Ltd. | 9.905M |
| NewCelX Ltd. | 1.118M |
Market Cap Related Metrics
| PS Ratio | 10.11 |
| Price to Free Cash Flow | 64.27 |
| Price | 39.85 |
| Earnings Yield | 0.80% |
| Operating PE Ratio | 64.94 |
| Normalized PE Ratio | 112.67 |